Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lilly(Eli) & Co shares valued at $494,627 were purchased by Montarce Lucas on Aug 15 ’25. At $691.79 per share, Montarce Lucas acquired 715 shares. The insider’s holdings grew to 14,685 shares worth approximately $10.42 million following the completion of this transaction.
Also, Alvarez Ralph purchased 758 shares, netting a total of over 500,473 in proceeds. Following the buying of shares at $660.25 each, the insider now holds 758 shares.
Before that, Van Naarden Jacob had added 1,000 shares to its account. In a trade valued at $647,360, the EVP & Pres., Lilly Oncology bought Lilly(Eli) & Co shares for $647.36 each. Upon closing the transaction, the insider’s holdings increased to 1,000 shares, worth approximately $14.6 million.
As published in a research note from Daiwa Securities on August 18, 2025, Lilly(Eli) & Co [LLY] has been rated down from an Outperform to a Neutral and the price target has been revised to $700. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in early August. As of June 05, 2025, Erste Group has decreased its “Buy” rating to a “Hold” for LLY. Earlier on April 28, 2025, HSBC Securities downgraded its rating. Their new recommendation was “a Reduce” for LLY stock which previously was a “a Buy”.
Analyzing LLY Stock Performance
On last trading session, Lilly(Eli) & Co [NYSE: LLY] rose 0.62% to $709.82. The stock’s lowest price that day was $705.9, but it reached a high of $718.39 in the same session. During the last five days, there has been a surge of approximately 3.71%. Over the course of the year, Lilly(Eli) & Co shares have dropped approximately -23.00%. Shares of the company reached a 52-week high of $935.63 on 03/03/25 and a 52-week low of $623.78 on 08/08/25.
Support And Resistance Levels for Lilly(Eli) & Co (LLY)
According to the 24-hour chart, there is a support level at 703.88, which, if violated, would cause prices to drop to 697.94. In the upper region, resistance lies at 717.08. The next price resistance is at 724.34. RSI (Relative Strength Index) is 46.85 on the 14-day chart, showing neutral technical sentiment.
Is Lilly(Eli) & Co subject to short interest?
Stocks of Lilly(Eli) & Co saw a sharp steep in short interest on 2025-07-31 dropping by -0.54 million shares to 7.17 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 7.71 million shares. A decline of -7.55% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.2 of the overall float, the days-to-cover ratio (short ratio) decline to 2.2.
Which companies own the most shares of Lilly(Eli) & Co (LLY)?
In terms of Lilly(Eli) & Co share price expectations, FactSet research, analysts set an average price target of 770 in the next 12 months, up nearly 9.15% from the previous closing price of $705.44. Analysts anticipate Lilly(Eli) & Co stock to reach 1146 by 2025, with the lowest price target being 700. In spite of this, 19 analysts ranked Lilly(Eli) & Co stock as Buy at the end of 2025. On April 22, 2025, Cantor Fitzgerald assigned a price target of “an Overweight” to the stock and initiated coverage with a $975.
